Origenis Establishes and Consolidates Presence in U.S. Investor Community
- Establish company presence among U.S. investors and raise fund in the U.S. for a European central nervous system biotechnology company
- Created messages and revised corporate presentation (LHS Immersion®)
- Identified and conducted outreach to targeted U.S. investors and high value partners
- Organized and facilitated investor meetings at BIO Investor Forum, Bio-Europe, Biotech Showcase, Sachs Forums, and non-deal roadshow on the east coast
- Provided strategic counseling on Series A fundraising in the U.S.
- Introduced company to approximately 500 U.S. investors
- Initiated and managed more than 40 investor meetings both on site and via telecon
- Conducted substantial conversations with 7 investment firms under confidential disclosure agreement
- Currently in the process of finalizing a syndicate
